<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04944498</url>
  </required_header>
  <id_info>
    <org_study_id>KE/FK/0525/EC/2019</org_study_id>
    <nct_id>NCT04944498</nct_id>
  </id_info>
  <brief_title>Modified Tarsorrhaphy vs Gold Weight Implant for Paralytic Lagophthalmos in Leprosy Patients</brief_title>
  <official_title>Modified Tarsorrhaphy vs Gold Weight Implant Technique for Paralytic Lagophthalmos Treatment in Leprosy Patients: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yunia Irawati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gadjah Mada University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the effectivity and efficiency of Modified Tarsorrhaphy (MT)&#xD;
      technique and Gold Weight Implant (GWI) technique as a surgical treatment of paralytic&#xD;
      lagophthalmos in leprosy patients. The hypothesis is that MT technique is more effective and&#xD;
      more efficient than GWI technique. This study used PROBE (Prospective Randomized Open-label&#xD;
      Blinded-Endpoint) clinical trial. Samples consisted of 14 eyes in MT group and 13 eyes in GWI&#xD;
      group as the control group. This study was conducted in 3 hospitals in Indonesia and the&#xD;
      patients were observed in 1 year period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 9, 2019</start_date>
  <completion_date type="Actual">April 4, 2021</completion_date>
  <primary_completion_date type="Actual">February 9, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>Treatment received by patients was randomized by research team members. The investigator as the oculoplastic surgeon (YI) acknowledged the treatment assigned to each patient based on randomization. Outcomes were measured by other oculoplastic surgeons with equal clinical experiences.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance without pressure</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lagophthalmos distance with gentle pressure</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Eyelid margin distance in central, nasal, and temporal area measured in millimeters after applying minimal pressure on upper eyelid</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>3 month post-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>OSDI (Ocular Surface Disease Index)</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Questionnaire assessing subjective dry eyes symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TBUT (Tear Break-Up Time)</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Examination of tear break up time with fluorescein dye assessed with cobalt blue light from slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TBUT (Tear Break-Up Time)</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Examination of tear break up time with fluorescein dye assessed with cobalt blue light from slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TBUT (Tear Break-Up Time)</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Examination of tear break up time with fluorescein dye assessed with cobalt blue light from slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TBUT (Tear Break-Up Time)</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Examination of tear break up time with fluorescein dye assessed with cobalt blue light from slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TBUT (Tear Break-Up Time)</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Examination of tear break up time with fluorescein dye assessed with cobalt blue light from slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test without anesthesia</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper without anesthesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Schirmer test with anesthesia</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Tear film excretion examined using Whatman filter paper with anesthesia prior to examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epitheliopathy</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Epitheliopathy occurence, assessed with fluorescent dye and observed with cobalt blue light filter of slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epitheliopathy</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Epitheliopathy occurence, assessed with fluorescent dye and observed with cobalt blue light filter of slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epitheliopathy</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Epitheliopathy occurence, assessed with fluorescent dye and observed with cobalt blue light filter of slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epitheliopathy</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Epitheliopathy occurence, assessed with fluorescent dye and observed with cobalt blue light filter of slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Epitheliopathy</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Epitheliopathy occurence, assessed with fluorescent dye and observed with cobalt blue light filter of slit lamp</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal exposure</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Exposed distance of cornea when the eye was closed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal exposure</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Exposed distance of cornea when the eye was closed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal exposure</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Exposed distance of cornea when the eye was closed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal exposure</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Exposed distance of cornea when the eye was closed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal exposure</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Exposed distance of cornea when the eye was closed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal sensibility</measure>
    <time_frame>Pre-operative</time_frame>
    <description>Sensibility measured in millimeters by using Luneau Cohcet-Bonnet Aesthesiometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal sensibility</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Sensibility measured in millimeters by using Luneau Cohcet-Bonnet Aesthesiometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal sensibility</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Sensibility measured in millimeters by using Luneau Cohcet-Bonnet Aesthesiometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal sensibility</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Sensibility measured in millimeters by using Luneau Cohcet-Bonnet Aesthesiometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal sensibility</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Sensibility measured in millimeters by using Luneau Cohcet-Bonnet Aesthesiometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>intraoperative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>1 day post-operative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>7 day post-operative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>1 month post-operative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>3 months post-operative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Complication during surgery and after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Duration of surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cost</measure>
    <time_frame>1 year post-operative</time_frame>
    <description>Cost of surgery</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Paralytic Lagophthalmos</condition>
  <condition>Leprosy--Patients</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who received surgery with modified tarsorrhaphy technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who received surgery with gold weight implant technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modified Tarsorrhaphy</intervention_name>
    <description>A combination of levator recess, lateral tarsorrhaphy of 10 mm, and lateral canthopexy/lateral tarsal strip</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Gold Weight Implant</intervention_name>
    <description>Installation of 1,5 gram gold weight implant above tarsal plate and underneath levator recess</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  paucibacillary (PB) or multibacillary (MB) type leprosy patient with&#xD;
             unilateral/bilateral lagophthalmos who had not undergone eyelid reconstruction&#xD;
&#xD;
          -  patient aged 18 years old or older who could be performed surgery with local&#xD;
             anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient with acute leprosy reaction (&lt;6 months) and in steroid medication&#xD;
&#xD;
          -  patient with eyelid laxity &gt;8 mm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunia Irawati, Ophthalmologist Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>dr. Cipto Mangunkusumo Kirana Eye Hospital</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10320</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jakarta Eye Center Hospitals and Clinics</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10310</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>dr. Tadjuddin Chalid General Hospital</name>
      <address>
        <city>Makassar</city>
        <state>South Sulawesi</state>
        <zip>90241</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Pereira MV, Glória AL. Lagophthalmos. Semin Ophthalmol. 2010 May;25(3):72-8. doi: 10.3109/08820538.2010.488578. Review.</citation>
    <PMID>20590416</PMID>
  </reference>
  <reference>
    <citation>El Toukhy E. Gold weight implants in the management of lagophthalmos in leprosy patients. Lepr Rev. 2010 Mar;81(1):79-81.</citation>
    <PMID>20496572</PMID>
  </reference>
  <reference>
    <citation>Daniel E, Koshy S, Joseph GA, Rao PS. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India. Indian J Ophthalmol. 2003 Jun;51(2):155-9.</citation>
    <PMID>12831146</PMID>
  </reference>
  <reference>
    <citation>Nemet AY. Augmentation of lateral tarsorrhaphy in lagophthalmos. Orbit. 2014 Aug;33(4):289-91. doi: 10.3109/01676830.2014.894537. Epub 2014 Apr 30.</citation>
    <PMID>24786615</PMID>
  </reference>
  <reference>
    <citation>Aggarwal E, Naik MN, Honavar SG. Effectiveness of the gold weight trial procedure in predicting the ideal weight for lid loading in facial palsy: a prospective study. Am J Ophthalmol. 2007 Jun;143(6):1009-1012. Epub 2007 Apr 20.</citation>
    <PMID>17449001</PMID>
  </reference>
  <reference>
    <citation>Hontanilla B. Weight measurement of upper eyelid gold implants for lagophthalmos in facial paralysis. Plast Reconstr Surg. 2001 Nov;108(6):1539-43.</citation>
    <PMID>11711925</PMID>
  </reference>
  <reference>
    <citation>Lamba PA, Srinivasan R, Rohatgi J. Surgical management in ocular leprosy. Indian J Ophthalmol. 1987 May-Jun;35(3):153-7.</citation>
    <PMID>3507412</PMID>
  </reference>
  <reference>
    <citation>Koshy S, Daniel E, Kurian N, Yovan P. Pathogenesis of dry eye in leprosy and tear functions. Int J Lepr Other Mycobact Dis. 2001 Sep;69(3):215-8.</citation>
    <PMID>11875765</PMID>
  </reference>
  <reference>
    <citation>Li W, Yeh TN, Leung T, Yuen T, Lerma M, Lin MC. The Relationship of Lid Wiper Epitheliopathy to Ocular Surface Signs and Symptoms. Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1878-1887. doi: 10.1167/iovs.17-23639.</citation>
    <PMID>29677348</PMID>
  </reference>
  <reference>
    <citation>Harrisberg BP, Singh RP, Croxson GR, Taylor RF, McCluskey PJ. Long-term outcome of gold eyelid weights in patients with facial nerve palsy. Otol Neurotol. 2001 May;22(3):397-400.</citation>
    <PMID>11347647</PMID>
  </reference>
  <reference>
    <citation>Hieselaar LC, Hogeweg M, de Vries CL. Corneal sensitivity in patients with leprosy and in controls. Br J Ophthalmol. 1995 Nov;79(11):993-5.</citation>
    <PMID>8534670</PMID>
  </reference>
  <reference>
    <citation>Karaçorlu MA, Cakiner T, Saylan T. Corneal sensitivity and correlations between decreased sensitivity and anterior segment pathology in ocular leprosy. Br J Ophthalmol. 1991 Feb;75(2):117-9.</citation>
    <PMID>1995039</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 4, 2021</study_first_submitted>
  <study_first_submitted_qc>June 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2021</study_first_posted>
  <last_update_submitted>June 27, 2021</last_update_submitted>
  <last_update_submitted_qc>June 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Gadjah Mada University</investigator_affiliation>
    <investigator_full_name>Yunia Irawati</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hansen Disease</keyword>
  <keyword>Leprosy</keyword>
  <keyword>Paralytic lagophthalmos</keyword>
  <keyword>Surgical intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leprosy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

